Biochemistry of Parkinson's disease 28 years later: a critical review.
about
Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned ratsMemory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.Behavioral disturbances in Parkinson's diseaseAxial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulationFeedback timing modulates brain systems for learning in humans.Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP MiceDopamine and Consolidation of Episodic Memory: Timing is Everything.Milestones in Parkinson's disease--clinical and pathologic features.Milestones in Parkinson's disease therapeutics.Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease.Non-human primate models of PD to test novel therapies.The adrenal medulla and Parkinson's disease.A computational role for dopamine delivery in human decision-making.A trade-off between feedback-based learning and episodic memory for feedback events: evidence from Parkinson's disease.Apathy in patients with Parkinson disease as a function of side of onset.Single-dose levodopa administration and aging independently disrupt time production.Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease.The premorbid personality of patients with Parkinson's disease: evidence with the Tridimensional Personality Questionnaire.The effects of closed head injury, senile dementia of the Alzheimer's type, and Parkinson's disease on covert orientation of visual attentionLongitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs
P2860
Q27310170-90B28581-3447-4C14-848C-2197A2F970C0Q30470435-A13BD5F3-DC2A-4D01-9DEA-936BBA6C5FB8Q35236819-7857F6A9-3673-4714-B7E9-D3B6E8537B2BQ35456828-DBB1FBA1-4AC9-4E3F-84FD-2EA5256DDB4BQ35895397-63C6AE37-1B3E-4120-B68D-19EE22648B22Q35951218-8C4A248A-732D-489B-AFF9-196302A0D9B4Q36935143-ABBC4EBD-8683-4A62-8492-A875583D3344Q37882587-AAF5678E-07C6-4ED3-8B23-DB18A7211FEAQ37882596-7DC01E31-F8E3-4BB0-B752-13D17BE15D20Q38660355-F93643B3-A7E9-45D4-BDE3-B01CA8BCA108Q39229450-55330A8C-5541-448B-8FDC-15765ABA5DF3Q40494278-C9B05C4D-9AFC-4090-A220-5F512373B0E5Q40836768-19F2907A-D705-4B7E-BD80-B931BE5E5641Q45105682-FF9F8177-ACAA-4108-A613-BFE3E76AD735Q46795038-4BD5CF56-0FAD-42FA-8DE6-302314FFFD94Q46972356-80521FE5-1844-44BB-9216-EE07FA31230AQ51912495-3807A7D1-3A1F-42DC-A325-5969AE8CD76AQ53794013-E83083C2-D72F-4150-8523-437F5BD50397Q57405227-BBBA1E30-8EF8-4154-AB0B-64F82A902D34Q57794605-E25EE6E8-F21A-4DFB-B852-575D2881AE84
P2860
Biochemistry of Parkinson's disease 28 years later: a critical review.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Biochemistry of Parkinson's disease 28 years later: a critical review.
@en
type
label
Biochemistry of Parkinson's disease 28 years later: a critical review.
@en
prefLabel
Biochemistry of Parkinson's disease 28 years later: a critical review.
@en
P2093
P2860
P356
P1433
P1476
Biochemistry of Parkinson's disease 28 years later: a critical review.
@en
P2093
P2860
P304
P356
10.1002/MDS.870040514
P407
P478
P50
P577
1989-01-01T00:00:00Z